Browse the corpus

Walk the evidence base by book and chapter — the raw source passages that ground Ask, Differential, and the rest.

• "Can Magnetic Resonance Enterography (MRE) replace ileo-colonoscopy for evaluating disease activity in Crohn's disease?"1 passage
• A review of the epidemiology of Barrett's oesophagus and oesophageal adenocarcinoma.1 passage
• Abdominal Imaging in pregnancy (maternal and foetal risks).1 passage
• Accrediting for screening-related colonoscopy services: What is required of the endoscopist and of the endoscopy service?1 passage
• Acid suppression and surgical therapy for Barrett's oesophagus.1 passage
• Acquired causes of intestinal malabsorption.1 passage
• Acquiring and maintaining competency in gastrointestinal endoscopy.1 passage
• Action and function of Akkermansia muciniphila in microbiome ecology, health and disease.1 passage
• Action and function of Chromobacterium violaceum in health and disease: Violacein as a promising metabolite to counteract gastroenterological diseases.1 passage
• Action and function of Faecalibacterium prausnitzii in health and disease.1 passage
• Acute kidney injury after liver transplantation: Recent insights and future perspectives.1 passage
• Acute mesenteric ischemia (Part II) - Vascular and endovascular surgical approaches.1 passage
• Acute mesenteric ischemia (part I) - Incidence, etiologies, and how to improve early diagnosis.1 passage
• Acute severe ulcerative colitis: State of the art treatment.1 passage
• Adaptive diagnosis of coeliac disease.1 passage
• Adenoma detection rate and risk of colorectal cancer.1 passage
• Advanced endoscopic imaging for early gastric cancer.1 passage
• Adverse effects of immunosuppression after liver transplantation.1 passage
• Alcohol and other substance use after liver transplant.1 passage
• Alcohol use and smoking after liver transplantation; complications and prevention.1 passage
• Alcohol, smoking and benign hepato-biliary disease.1 passage
• Alcohol, smoking and risk of oesophago-gastric cancer.1 passage
• Alcohol, smoking and the liver disease patient.1 passage
• Alcohol, smoking and the risk of premalignant and malignant colorectal neoplasms.1 passage
• Allergic mechanisms of Eosinophilic oesophagitis.1 passage
• An allergist's perspective to the evaluation of Eosinophilic Esophagitis.1 passage
• An overview of acute gastrointestinal side effects of systemic anti-cancer therapy and their management.1 passage
• Anal cancer - What is the optimum chemoradiotherapy?1 passage
• Animal models of HBV infection.1 passage
• Artificial intelligence in biliopancreatic endoscopy: Is there any role?1 passage
• Artificial intelligence: Thinking outside the box.1 passage
• Assessment of a cancer screening program.1 passage
• Assessment of intestinal malabsorption.1 passage
• Assessments and skills improvement for endoscopists.1 passage
• Audit and feedback interventions to improve endoscopist performance: Principles and effectiveness.1 passage
• Barrett esophagus: What to expect from Artificial Intelligence?1 passage
• Barrett's oesophagus diagnostic criteria: endoscopy and histology.1 passage
• Barrett's oesophagus: can meaningful screening and surveillance guidelines be formulated based on new data and rejigging the old paradigm?1 passage
• Barrett's oesophagus: frequency and prediction of dysplasia and cancer.1 passage
• Barrett's oesophagus: treatment with surgery.1 passage
• Biliary complications after liver transplantation; recent developments in etiology, diagnosis and endoscopic treatment.1 passage
• Biosimilars in ulcerative colitis: When and for who?1 passage
• Can IL-23 be a good target for ulcerative colitis?1 passage
• Can image-enhanced cholangioscopy distinguish benign from malignant lesions in the biliary duct?1 passage
• Can we move directly from 5-ASA to a biologic agent in ulcerative colitis?1 passage
• Cardiovascular and metabolic disease in the liver transplant recipient.1 passage
• Celiac disease from a global perspective.1 passage
• Changes to gastrointestinal function after surgery for colorectal cancer.1 passage
• Changing epidemiology and etiology of upper and lower gastrointestinal bleeding.1 passage
• Changing epidemiology of hepatocellular carcinoma in Asia.1 passage
• Characterization of lesions in the stomach: will confocal laser endomicroscopy replace the pathologist?1 passage
• Chemoprevention in Barrett's oesophagus.1 passage
• Chemoprevention trials of GI cancers in Asia.1 passage
• Chemoradiation in oesophageal cancer.1 passage
• Chemoradiotherapy in tumours of the oesophagus and gastro-oesophageal junction.1 passage
• Chemotherapeutic agents for GI tumor chemoradiotherapy overview of chemotherapeutic agents to be combined with radiotherapy in the GI tract and their potential as radiosensitizers.1 passage
• Chemotherapy and novel targeted therapies for operable esophageal and gastroesophageal junctional cancer.1 passage
• Chronic diarrhoea in an oncology patient - Clinical assessment and decision making.1 passage
• Clinical features of Eosinophilic esophagitis in children and adults.1 passage
• Clinical presentation, risk factors and staging systems of cholangiocarcinoma.1 passage
• Colon ischemia: Right-sided colon involvement has a different presentation, etiology and worse outcome. A large retrospective cohort study in histology proven patients.1 passage
• Colorectal cancer prevention in patients with ulcerative colitis.1 passage
• Colorectal endoscopic mucosal resection (EMR).1 passage
• Colorectal endoscopic submucosal dissection (ESD).1 passage
• Colorectal polyp characterization with endocytoscopy: Ready for widespread implementation with artificial intelligence?1 passage
• Colorectal polyp characterization with standard endoscopy: Will Artificial Intelligence succeed where human eyes failed?1 passage
• Communication of alcohol and smoking lifestyle advice to the gastroenterological patient.1 passage
• Complications in pediatric endoscopy.1 passage
• Complications of ERCP.1 passage
• Complications of coeliac disease.1 passage
• Complications of diagnostic and therapeutic Endoscopic Ultrasound.1 passage
• Complications of diagnostic colonoscopy, upper endoscopy, and enteroscopy.1 passage
• Complications of endoscopic polypectomy, endoscopic mucosal resection and endoscopic submucosal dissection in the colon.1 passage
• Complications of endoscopic resection techniques for upper GI tract lesions.1 passage
• Complications of percutaneous endoscopic gastrostomy.1 passage
• Complications of submucosal endoscopy.1 passage
• Complications of therapeutic gastroscopy/colonoscopy other than resection.1 passage
• Congenital intestinal diarrhoeal diseases: A diagnostic and therapeutic challenge.1 passage
• Cost considerations in implementing a screening and surveillance strategy for Barrett's oesophagus.1 passage
• Cost effectiveness of surveillance for GI cancers.1 passage
• Cost-effectiveness of prevention and early detection of gastric cancer in Western countries.1 passage
• Current treatment guidelines of chronic hepatitis B: The role of nucleos(t)ide analogues and peginterferon.1 passage
• De novo and recurrent liver disease.1 passage
• De novo and recurrent malignancy.1 passage
• Definitions of intestinal failure and the short bowel syndrome.1 passage
• Detection and characterization of early malignancy in the esophagus: what is the best management algorithm?1 passage
• Detection of flat colorectal neoplasia by artificial intelligence: A systematic review.1 passage
• Diagnosis and treatment of chronic mesenteric ischemia: An update.1 passage
• Diagnosis by endoscopy and advanced imaging.1 passage
• Diagnostic approach to eosinophilic oesophagitis: Pearls and pitfalls.1 passage
• Diet, microbiome, and colorectal cancer.1 passage
• Disease associations in eosinophilic oesophagitis and oesophageal eosinophilia.1 passage
• Distribution of colorectal polyps: Implications for screening.1 passage
• Do smoking and alcohol behaviours influence GI cancer survival?1 passage
• Dysbiosis in gastrointestinal disorders.1 passage
• Early detection of gastric cancer beyond endoscopy - new methods.1 passage
• Early esophageal cancer screening in China.1 passage
• Early gastric cancer and Artificial Intelligence: Is it time for population screening?1 passage
• Effect of biologicals and JAK inhibitors during pregnancy on health-related outcomes in children of women with inflammatory bowel disease.1 passage
• Effect of frequently prescribed drugs on gastric cancer risk.1 passage
• Effective screening for early diagnosis of pancreatic cancer.1 passage
• Elimination and elemental diet therapy in eosinophilic oesophagitis.1 passage
• Endoscopic diagnosis of cholangiocarcinoma: From endoscopic retrograde cholangiography to bile proteomics.1 passage
• Endoscopic management of dysplasia and early oesophageal cancer.1 passage
• Endoscopic management of nonvariceal upper gastrointestinal bleeding.1 passage
• Endoscopic scoring systems for the evaluation and monitoring of disease activity in Crohn's disease.1 passage
• Endoscopic therapy for Barrett's oesophagus.1 passage
• Enteral approaches in malabsorption.1 passage
• Environmental and infectious factors in eosinophilic esophagitis.1 passage
• Epidemiology and risk factors of colorectal polyps.1 passage
• Epidemiology of cholangiocarcinoma.1 passage
• Epidemiology of hepatitis B and the role of vaccination.1 passage
• Esophageal dilation in eosinophilic esophagitis.1 passage
• Esophageal squamous dysplasia and cancer: Is artificial intelligence our best weapon?1 passage
• Evaluation and management of gastric epithelial polyps.1 passage
• Evolution of our understanding of PBC.1 passage
• Evolution of treatment targets in Crohn's disease.1 passage
• Follow-up of liver transplant recipients.1 passage
• From organoids to organs: Bioengineering liver grafts from hepatic stem cells and matrix.1 passage
• Functional testing in the diagnosis of chronic mesenteric ischemia.1 passage
• Future directions in the treatment of cholangiocarcinoma.1 passage
• Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS) - A Helicobacter-opposite point.1 passage
• Gastric cancer adjuvant therapy.1 passage
• Gastric cancer- endoscopic treatment of early lesions, the West learns from the East.1 passage
• Gastrointestinal side effects of upper gastrointestinal cancer surgery.1 passage
• Genetics of celiac disease.1 passage
• Geoepidemiology and (epi-)genetics in primary biliary cholangitis.1 passage
• Helicobacter pylori eradication in dyspepsia: New evidence for symptomatic benefit.1 passage
• Helicobacter pylori induced gastric carcinogenesis - The best molecular model we have?1 passage
• Hepatitis B vaccination and prevention of hepatocellular carcinoma.1 passage
• Hepatitis B virus infection and the immune response: The big questions.1 passage
• Hepatitis E virus: A potential threat for patients with liver disease and liver transplantation.1 passage
• Hepatitis delta infection - Current and new treatment options.1 passage
• Hereditary or sporadic polyposis syndromes.1 passage
• High-resolution microendoscopy in differentiating neoplastic from non-neoplastic colorectal polyps.1 passage
• Histological and molecular classification of gastrointestinal polyps.1 passage
• Hypo- and normothermic perfusion of the liver: Which way to go?1 passage
• IL12/23 or selective IL23 inhibition for the management of moderate-to-severe Crohn's disease?1 passage
• Image-enhanced capsule endoscopy for characterization of small bowel lesions.1 passage
• Image-enhanced endoscopy technology in the gastrointestinal tract: what is available?1 passage
• Immunosuppressants and immune modulators in luminal gastroenterology.1 passage
• Immunosuppression in gastroenterology and hepatology.1 passage
• Immunosuppression in liver and intestinal transplantation.1 passage
• Immunosuppression in liver transplant.1 passage
• Immunosuppressive drugs modes of action.1 passage
• Immunotherapy induced enterocolitis and gastritis - What to do and when?1 passage
• Impact of alcohol & smoking on the surgical management of gastrointestinal patients.1 passage
• Impact of artificial intelligence on colorectal polyp detection.1 passage
• Impact of gastric cancer treatment on quality of life of patients.1 passage
• Improving prognosis in primary biliary cholangitis - Therapeutic options and strategy.1 passage
• In the absence of head-to-head trials, what do real world studies tell us about the comparative effectiveness of biologics in Crohn's disease.1 passage
• In vivo identification of pancreatic cystic neoplasms with needle-based confocal laser endomicroscopy.1 passage
• In-training gastrointestinal endoscopy competency assessment tools: Types of tools, validation and impact.1 passage
• Infectious complications in gastrointestinal endoscopy and their prevention.1 passage
• Innate immunity: actuating the gears of celiac disease pathogenesis.1 passage
• Insights into the emerging epidemic of eosinophilic oesophagitis.1 passage
• Integration of chemoembolization and radioembolization into multimodal treatment of cholangiocarcinoma.1 passage
• Interactions between gastro-oesophageal reflux disease and eosinophilic oesophagitis.1 passage
• Interfering with leukocyte trafficking in Crohn's disease.1 passage
• Interferon-free antiviral therapy for chronic hepatitis C among patients in the liver transplant setting.1 passage
• Intervening in disease through genetically-modified bacteria.1 passage
• Intestinal microbiome and permeability in patients with autoimmune hepatitis.1 passage
• Intestinal microbiota in liver disease.1 passage
• Intestinal transplantation.1 passage
• Is PBC a viral infectious disease?1 passage
• Is there still a role for the surgeon in the management of gastrointestinal bleeding ?1 passage
• JAK inhibitors: Novel developments in management of ulcerative colitis.1 passage
• Key role of local acetaldehyde in upper GI tract carcinogenesis.1 passage
• Leadership and team building in gastrointestinal endoscopy.1 passage
• Learning curve for endoscopy training: Is it all about numbers?1 passage
• Lifestyle alters GUT-bacteria function: Linking immune response and host.1 passage
• Management of duodenal polyps.1 passage
• Management of hepatitis B in special populations.1 passage
• Management of radiation and chemotherapy related acute toxicity in gastrointestinal cancer.1 passage
• Management of small bowel polyps: A literature review.1 passage
• Managing antithrombotic agents during endoscopy.1 passage
• Measures of trainee performance in advanced endoscopy: A systematic review.1 passage
• Mechanism and prediction of HCC development in HBV infection.1 passage
• Mechanisms of Barrett's oesophagus (clinical): LOS dysfunction, hiatal hernia, peristaltic defects.1 passage
• Mechanisms of Barrett's oesophagus: intestinal differentiation, stem cells, and tissue models.1 passage
• Mechanisms of intestinal adaptation.1 passage
• Medical therapy in eosinophilic oesophagitis.1 passage
• Methodological considerations for surveillance in GI practice.1 passage
• Methods to become a high performer in characterization of colorectal polyp histology.1 passage
• Microbial perturbations and modulation in conditions associated with malnutrition and malabsorption.1 passage
• Microbiome measurement: Possibilities and pitfalls.1 passage
• Microbiome, pattern recognition receptor function in health and inflammation.1 passage
• Modification of immunosuppressive therapy as risk factor for complications after liver transplantation.1 passage
• Molecular biomarkers added to image-enhanced endoscopic imaging: will they further improve diagnostic accuracy?1 passage
• Molecular modelling of the gastric barrier response, from infection to carcinogenesis.1 passage
• Molecular pathways in the development and treatment of oesophageal cancer.1 passage
• Morphological classifications of gastrointestinal lesions.1 passage
• Multi-modal and sequential treatment of liver cancer and its impact on the gastrointestinal tract.1 passage
• NAFLD, Helicobacter species and the intestinal microbiome.1 passage
• Natural history of acute and chronic hepatitis B: The role of HBV genotypes and mutants.1 passage
• Neoadjuvant chemoradiotherapy for resectable oesophageal cancer.1 passage
• Network meta-analysis to inform positioning of biologics in patients with Crohn's disease: Promise and perils.1 passage
• New agents for immunosuppression.1 passage
• New treatments to reach functional cure: Rationale and challenges for emerging immune-based therapies.1 passage
• New treatments to reach functional cure: Virological approaches.1 passage
• Non-adherence and transition clinics.1 passage
• Non-celiac gluten sensitivity: a work-in-progress entity in the spectrum of wheat-related disorders.1 passage
• Non-celiac wheat sensitivity: differential diagnosis, triggers and implications.1 passage
• Non-invasive screening for colorectal cancer in Asia.1 passage
• Non-obstetric surgery in pregnancy (including bowel surgery and gallbladder surgery).1 passage
• Novel approaches: Tissue engineering and stem cells--In vitro modelling of the gut.1 passage
• Novel imaging techniques in staging oesophageal cancer.1 passage
• Nutrition and gastroenterological support in end of life care.1 passage
• Oesophagectomy: The expanding role of minimally invasive surgery in oesophageal cancer.1 passage
• Oesophagus side effects related to the treatment of oesophageal cancer or radiotherapy of other thoracic malignancies.1 passage
• Optical diagnosis of small colorectal polyps during colonoscopy: when to resect and discard?1 passage
• Optimal management of the patient presenting with small bowel bleeding.1 passage
• Optimal timing of endoscopy in patients with acute upper gastrointestinal bleeding.1 passage
• Organization of surveillance in GI practice.1 passage
• Overcoming barriers to implementation of artificial intelligence in gastroenterology.1 passage
• Overview of gastrointestinal cancer prevention in Asia.1 passage
• PBC and related extrahepatic diseases.1 passage
• PBC-transplantation and disease recurrence.1 passage
• Palliation of dysphagia.1 passage
• Pancreatic cancer chemoradiotherapy.1 passage
• Parenteral approaches in malabsorption: Home parenteral nutrition.1 passage
• Pathogenesis of cholangiocarcinoma: From genetics to signalling pathways.1 passage
• Pathologic classification of cholangiocarcinoma: New concepts.1 passage
• Pathophysiology of primary biliary cholangitis.1 passage
• Pathophysiology of the irritable bowel syndrome - Reflections of today.1 passage
• Patterns of disease progression and incidence of complications in primary biliary cholangitis (PBC).1 passage
• Pharmacological secondary prevention in patients with mesenterial artery atherosclerosis and arterial embolism.1 passage
• Pharmacology, efficacy and safety of JAK inhibitors in Crohn's disease.1 passage
• Physiology of Intestinal Absorption and Secretion.1 passage
• Pitfalls in training and validation of deep learning systems.1 passage
• Polyp characterization at colonoscopy: Clinical implications.1 passage
• Polyp detection at colonoscopy: Endoscopist and technical factors.1 passage
• Post liver transplant recurrent and de novo viral infections.1 passage
• Pre-existing liver disease in pregnancy: Cirrhosis, autoimmune hepatitis and liver transplantation.1 passage
• Prebiotics: Definition and protective mechanisms.1 passage
• Preconception counseling of females with inflammatory bowel disease.1 passage
• Preoperative evaluation of oesophageal adenocarcinoma.1 passage
• Preventing complications in celiac disease: our experience with managing adult celiac disease.1 passage
• Prevention strategies for esophageal cancer: Perspectives of the East vs. West.1 passage
• Primary biliary cholangitis and bone disease.1 passage
• Probiotics and prebiotics in Crohn's disease therapies.1 passage
• Probiotics and prebiotics in infectious gastroenteritis.1 passage
• Probiotics and prebiotics in ulcerative colitis.1 passage
• Probiotics in Helicobacter pylori-induced peptic ulcer disease.1 passage
• Probiotics in functional bowel disorders.1 passage
• Probiotics, prebiotics and colorectal cancer prevention.1 passage
• Probiotics: definition, scope and mechanisms of action.1 passage
• Promoting intestinal adaptation by nutrition and medication.1 passage
• Proton pump inhibitors for upper gastrointestinal bleeding.1 passage
• Pseudo-obstruction, enteric dysmotility and irritable bowel syndrome.1 passage
• Quality of life after liver transplantation.1 passage
• Radiation therapy in cholangiocellular carcinomas.1 passage
• Radiation-induced damage in the lower gastrointestinal tract: Clinical presentation, diagnostic tests and treatment options.1 passage
• Radiation-induced damage in the upper gastrointestinal tract: clinical presentation, diagnostic tests and treatment options.1 passage
• Radiological diagnosis in cholangiocarcinoma: Application of computed tomography, magnetic resonance imaging, and positron emission tomography.1 passage
• Recent progress in gastric cancer prevention.1 passage
• Rectal cancer: Neoadjuvant chemoradiotherapy.1 passage
• Recurrence of primary sclerosing cholangitis, primary biliary cholangitis and auto-immune hepatitis after liver transplantation.1 passage
• Red flag imaging in Barrett's esophagus: does it help to find the needle in the haystack?1 passage
• Reflux esophagitis, functional and non-functional.1 passage
• Renal disease in the allograft recipient.1 passage
• Reversal of liver fibrosis: From fiction to reality.1 passage
• Review on gastrointestinal angiodysplasia throughout the gastrointestinal tract.1 passage
• Review: Surveillance of patients with Barrett oesophagus.1 passage
• Risk factors and populations at risk: selection of patients for screening for Barrett's oesophagus.1 passage
• Risk factors for oesophageal cancer.1 passage
• Risk stratification and prognostic modelling in primary biliary cholangitis.1 passage
• Risk stratification in upper and upper and lower GI bleeding: Which scores should we use?1 passage
• Robot assisted minimally invasive esophagectomy (RAMIE) for esophageal cancer.1 passage
• Role of photodynamic therapy and intraductal radiofrequency ablation in cholangiocarcinoma.1 passage
• Role of surgery in cholangiocarcinoma: From resection to transplantation.1 passage
• Safety of biological therapies in ulcerative colitis: An umbrella review of meta-analyses.1 passage
• Screening of gastric cancer in Asia.1 passage
• Serological markers for human intestinal ischemia: A systematic review.1 passage
• Serrated lesions of the colon and rectum: the role of advanced endoscopic imaging.1 passage
• Should we use anti-tumor necrosis factor agents or vedolizumab as first-line biological therapy in ulcerative colitis?1 passage
• Should we use vedolizumab as mono or combo therapy in ulcerative colitis?1 passage
• Simulator training in gastrointestinal endoscopy - From basic training to advanced endoscopic procedures.1 passage
• Small Bowel Capsule Endoscopy and artificial intelligence: First or second reader?1 passage
• Standardisation of polypectomy technique.1 passage
• Stereotactic body radiation therapy for primary and metastatic liver tumors: From technological evolution to improved patient care.1 passage
• Striving for quality improvement: can artificial intelligence help?1 passage
• Surgery in ulcerative colitis: When? How?1 passage
• Surgical management and autologous intestinal reconstruction in short bowel syndrome.1 passage
• Surveillance after colorectal polyp removal.1 passage
• Surveillance after endoscopic and surgical resection of colorectal cancer.1 passage
• Surveillance for hepatocellular carcinoma.1 passage
• Surveillance for neoplasia in the pancreas.1 passage
• Surveillance in cholangiocellular carcinoma.1 passage
• Surveillance of long-standing colitis: the role of image-enhanced endoscopy.1 passage
• Surveillance of patients at high-risk of squamous cell esophageal cancer.1 passage
• Surveillance of patients with gastric precancerous conditions.1 passage
• Surveillance of patients with hereditary gastrointestinal cancer syndromes.1 passage
• Surveillance of patients with inflammatory bowel disease.1 passage
• Symptoms of PBC - Pathophysiology and management.1 passage
• Systemic therapy of cholangiocarcinoma: From chemotherapy to targeted therapies.1 passage
• T-cell and B-cell immunity in celiac disease.1 passage
• Tangible pathologies in functional dyspepsia.1 passage
• Targeted agents in GI radiotherapy: Clinical efficacy and side effects.1 passage
• Targeted and immunotherapy in the era of personalised gastric cancer treatment.1 passage
• Targeted screening for colorectal cancer in high-risk individuals.1 passage
• Targeting anti-fibrotic pathways in Crohn's disease - The final frontier?1 passage
• Testing for thrombophilia in mesenteric venous thrombosis - Retrospective original study and systematic review.1 passage
• Tests of intestinal mucosal hyperpermeability: Many diseases, many biomarkers and a bright future.1 passage
• The Rome IV: Irritable bowel syndrome - A functional disorder.1 passage
• The changing epidemiology of Asian digestive cancers: From etiologies and incidences to preventive strategies.1 passage
• The complexity of cancer origins at the gastro-oesophageal junction.1 passage
• The current place of probiotics and prebiotics in the treatment of pouchitis.1 passage
• The gastrointestinal microbiota and its role in oncogenesis.1 passage
• The genetic basis of eosinophilic esophagitis.1 passage
• The immune system and microbiome in pregnancy.1 passage
• The impact of biologics in surgical outcomes in ulcerative colitis.1 passage
• The impact of modulating the gastrointestinal microbiota in cancer patients.1 passage
• The impact of pregnancy on biologic therapies for the treatment of inflammatory bowel disease.1 passage
• The impact of recent next generation sequencing and the need for a new classification in gastric cancer.1 passage
• The influence of the gastric microbiota in gastric cancer development.1 passage
• The interaction between smoking, alcohol and the gut microbiome.1 passage
• The interpretation of liver function tests in pregnancy.1 passage
• The management of mid & proximal oesophageal squamous cell carcinoma.1 passage
• The optimal use of blood components in the management of gastrointestinal bleeding.1 passage
• The prevention of coeliac disease.1 passage
• The pros and cons of gastric bypass surgery - The role of the Roux-limb.1 passage
• The rationale of combined radiotherapy and chemotherapy - Joint action of Castor and Pollux.1 passage
• The role of adjuvant chemotherapy and radiotherapy for cholangiocarcinoma.1 passage
• The role of animal models in unravelling therapeutic targets in coeliac disease.1 passage
• The role of colonoscopy and endotherapy in the management of lower gastrointestinal bleeding.1 passage
• The role of definitive chemoradiation in patients with non-metastatic oesophageal cancer.1 passage
• The role of equipment in endoscopic complications.1 passage
• The role of smoking and alcohol behaviour in management of functional gastrointestinal disorders.1 passage
• The role of smoking and alcohol behaviour in the management of inflammatory bowel disease.1 passage
• The role of surgery in advanced disease for esophageal and junctional cancer.1 passage
• The role of surgery in the treatment of endoscopic complications.1 passage
• The treatment of refractory ulcerative colitis.1 passage
• The use of molecular markers in predicting dysplasia and guiding treatment.1 passage
• The use of old donors in liver transplantation.1 passage
• The virological aspects of hepatitis B.1 passage
• Therapeutic approaches for celiac disease.1 passage
• Therapeutic drug monitoring of immunosuppressive drugs in hepatology and gastroenterology.1 passage
• Therapeutic potential of an anaerobic cultured human intestinal microbiota, ACHIM, for treatment of IBS.1 passage
• Therapeutic strategies in eosinophilic esophagitis: Induction, maintenance and refractory disease.1 passage
• Tobacco and alcohol as risk factors for pancreatic cancer.1 passage
• Tobacco smoking, alcohol consumption and gastro-oesophageal reflux disease.1 passage
• Towards tolerance in liver transplantation.1 passage
• Training for advanced endoscopic procedures.1 passage
• Training non-physicians to do endoscopy: Feasibility, effectiveness and cost-effectiveness.1 passage
• Training the gastrointestinal endoscopy trainer.1 passage
• Treatment of hepatitis B virus with combination therapy now and in the future.1 passage
• Use of immunosuppression in non-transplant hepatology.1 passage
• Use of probiotics and prebiotics in infant feeding.1 passage
• Use of probiotics in prevention and treatment of patients with Clostridium difficile infection.1 passage
• Utility of animal gastrointestinal motility and transit models in functional gastrointestinal disorders.1 passage
• Variant syndromes of primary biliary cholangitis.1 passage
• Vascular imaging of the mesenteric vasculature.1 passage
• Vasculitis of the mesenteric circulation.1 passage
• Visceral aneurysms: Old paradigms, new insights?1 passage
• What is new on HBsAg and other diagnostic markers in HBV infection?1 passage
• What is the role of C-reactive protein and fecal calprotectin in evaluating Crohn's disease activity?1 passage
• What is the role of histopathology in the evaluation of disease activity in Crohn's disease?1 passage
• When all else fails - Radiological management of severe gastrointestinal bleeding.1 passage
• Which evidence for a treat to target strategy in ulcerative colitis?1 passage